Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.34 |
| ▸ | CRHBP | P24387 | 1/20 | 0.33 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16541081 | 0.67 | — | — | |
| SCHEMBL1571817 | 0.64 | — | — | |
| SCHEMBL8596528 | 0.61 | NOTUM (0.34) | KDM4EALDH1A1HPGD | |
| SCHEMBL11256496 | 0.59 | HTT (0.37) | KDM4E | |
| SCHEMBL17351370 | 0.58 | DGAT1 (0.35) | — | |
| Hydrochloric Acid SCHEMBL22188751 | 0.58 | MASP2 (0.38) | KDM4EALDH1A1 | |
| SCHEMBL20589156 | 0.58 | MASP2 (0.38) | KDM4EALDH1A1 | |
| SCHEMBL4406506 | 0.57 | — | — | |
| SCHEMBL20526119 | 0.57 | — | — | |
| Ammonia Solution, Strong SCHEMBL29243752 | 0.57 | HRH1 (0.38) | KDM4EHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1506169-B1 | METHOD FOR THE PRODUCTION OF SULPHONIC ACID DIAMIDES | BASF SE (DE) | 2009-12-23 | — | — | EP | disclosed |
| US-7232926-B2 | Method for the production of sulphamic acid halogenides | BASF AKTIENGESELLSCHAFT (DE) | 2007-06-19 | — | — | US | disclosed |
| US-20050159622-A1 | Method for the production of sulphamic acid halogenides | BASF AKTIENGESELLSCHAFT (DE) | 2005-07-21 | — | — | US | disclosed |
| EP-1506169-A1 | METHOD FOR THE PRODUCTION OF SULPHAMIC ACID HALOGENIDES | BASF AKTIENGESELLSCHAFT (DE) | 2005-02-16 | — | — | EP | disclosed |
| WO-2003097589-A1 | METHOD FOR THE PRODUCTION OF SULPHAMIC ACID HALOGENIDES | BASF AKTIENGESELLSCHAFT (DE) | 2003-11-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050159622-A1 | Method for the production of sulphamic acid halogenides | AS3MT, ARSA, SRM | KDM4E 2634/4885CRHBP 4858/4885CRHR2 4768/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.